RxDoctor Payments Data

Ellen Sanders, MD

Ophthalmology · Charlottesville, VANPI 1952586620

Payments from drug & device makers

$1,120in general payments, 2019–2025

Across 43 payments — averaging $26.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$664
  • Sun Pharmaceutical Industries Inc.$72
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$71
  • Johnson & Johnson Surgical Vision, Inc.$64
  • Harrow Eye, LLC$59
  • Aerie Pharmaceuticals, Inc.$41
  • plus $151 from 6 others

What the payments were for

  • Food & beverage$1,120100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,120 in reported general payments places this provider in the 50th percentile of 509 ophthalmology providers in Virginia.

See all ophthalmology providers in Virginia

Medicare billing

Part B allowed, 2024
$95,200
Medicare patients
453
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine39$39,050
XiidraLifitegrast12$13,432
Cyclosporine26$8,617
Ketorolac Tromethamine80$3,726
Prednisolone Acetate55$2,554
Fluorometholone14$751
MoxifloxacinMoxifloxacin Hcl25$664
Latanoprost39$399
Brimonidine Tartrate13$374
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha25$261

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →